학술논문
Invited commentary on … Lithium treatment and risk for dementia in adults with bipolar disorder.
Document Type
Academic Journal
Author
Sutherland C; Calum Sutherland, BSc, PhD, Division of Cardiovascular and Diabetes Medicine, Ninewells Medical School, Dundee, Scotland; Ashleigh C. Duthie, MRCPsych, MSc, Susan Carnegie Centre, Stracathro Hospital, near Brechin, Scotland c.d.sutherland@dundee.ac.uk.; Duthie AC; Calum Sutherland, BSc, PhD, Division of Cardiovascular and Diabetes Medicine, Ninewells Medical School, Dundee, Scotland; Ashleigh C. Duthie, MRCPsych, MSc, Susan Carnegie Centre, Stracathro Hospital, near Brechin, Scotland.
Source
Publisher: Cambridge University Press Country of Publication: England NLM ID: 0342367 Publication Model: Print Cited Medium: Internet ISSN: 1472-1465 (Electronic) Linking ISSN: 00071250 NLM ISO Abbreviation: Br J Psychiatry Subsets: MEDLINE
Subject
Language
English
Abstract
Alzheimer's disease clinical trials are failing at an alarming rate, highlighting the desperate need for novel thinking to combat this escalating health crisis. A recent large-scale population study indicates that lithium treatment reduces dementia development, supporting preclinical mechanistic evidence that this commonly used agent might be clinically valuable in dementia.
(© The Royal College of Psychiatrists 2015.)
(© The Royal College of Psychiatrists 2015.)